Quality Tested Third-Party Verified Highly Purified U.S. Based Expert Support
PhysIQ PeptidesPhysIQ Peptides
Back to Shop
IGF-1 LR3 1mg research peptide vial

IGF-1 LR3

Long Arg3 Insulin-Like Growth Factor-1

IGF-1 LR3 (Long Arg3 Insulin-like Growth Factor-1) is an 83-amino-acid recombinant analog of human IGF-1. It is structurally modified with an N-terminal 13-amino-acid extension peptide and a glutamic acid-to-arginine substitution at position 3. These structural modifications drastically lower its affinity for insulin-like growth factor-binding proteins (IGFBPs), allowing higher concentrations of the peptide to remain free and biologically active in experimental models.

Because endogenous IGFBPs typically sequester native IGF-1 and limit its receptor interaction, IGF-1 LR3 demonstrates a prolonged half-life and markedly enhanced biological potency in laboratory assays. This makes it an essential tool for evaluating IGF-1 receptor dynamics, autocrine and paracrine cellular communication, and downstream phosphorylation cascades without interference from binding proteins.

In preclinical research environments, IGF-1 LR3 is extensively utilized to probe pathways governing cellular proliferation, differentiation, protein synthesis, and metabolic homeostasis in various cell cultures and non-human tissue models. All products are intended solely for laboratory investigation and in vitro research.

Choose how to buy

Your first order ships at the regular price. Every reship after that is 5% off. Pause, change the interval, or cancel anytime.

$63.00per vial · 1mg
Ask a Question
Third-party tested · Purity ≥99% · For laboratory research use only.
Purity
≥99%
Form
Lyophilized powder
CAS Number
949837-92-9
Molecular Formula
C400H625N111O115S9
Molecular Weight
9117.5 g/mol
Available sizes
1mg

Sequence

MFPAMPLSSLFVNGPRTLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA

Mechanism of Action

IGF-1 LR3 functions by selectively binding to the type 1 IGF receptor (IGF-1R), a receptor tyrosine kinase located on the cell membrane. Ligand binding induces autophosphorylation of the receptor's intracellular kinase domains, recruiting docking proteins such as insulin receptor substrate 1 (IRS-1). This triggers two primary signaling pathways: the PI3K/Akt pathway, which promotes cell survival, glucose uptake, and anabolic protein synthesis via mTOR activation, and the MAPK/ERK pathway, which drives mitogenesis and cellular proliferation.

Unlike native IGF-1, the structural modifications of IGF-1 LR3 prevent sequestration by IGFBP-1 through IGFBP-6. Consequently, receptor binding and downstream kinase activation occur at significantly lower concentrations and persist over extended experimental timeframes, facilitating high-resolution study of sustained growth factor signaling.

Research Areas

  • ●Cellular proliferation and mitogenic signaling
  • ●mTOR and Akt pathway activation
  • ●Myoblast differentiation and hypertrophy models
  • ●Glucose transport and metabolic kinetics
  • ●Tissue regeneration and cellular senescence

Selected References

  • Tomas FM, et al. Biochem J. 1992;288(Pt 3):969-976.
  • Ballard FJ, et al. J Endocrinol. 1996;149(3):417-427.
  • Clemmons DR. Cytokine Growth Factor Rev. 2007;18(5-6):339-346.

Related Products

Ipamorelin research peptide vial

Ipamorelin

Purity
99%
Size
5mg
Form
Powder
$35.00Per Unit
KissPeptin-10 research peptide vial

KissPeptin-10

Purity
99%
Size
2 sizes
Form
Powder
From $37.00Per Unit
KPV research peptide vial

KPV

Purity
99%
Size
10mg
Form
Powder
$50.00Per Unit
LL-37 research peptide vial

LL-37

Purity
99%
Size
5mg
Form
Powder
$84.00Per Unit